Sanofi 2018 IR
The report highlights Sanofi's financial and ESG performance for the fiscal year 2018, marking a return to growth with net sales of ’34.5 billion. The company advanced its strategic roadmap by building a leading rare blood disorder franchise and refocusing its R&D pipeline on specialty care. Sanofi strengthened its corporate social responsibility governance by integrating CSR into the Board's Appointments and Governance Committee and introducing a CSR performance criterion in the CEO's compensation. Key environmental achievements include a 9% reduction in CO2 emissions and a 14% reduction in water consumption since 2015, alongside joining the Science Based Targets initiative.
Company: Sanofi
Sector: Health Care
Country: France
Year: 2018
Type: IR
Pages: 28
Back to company
Sanofi
Integrated Report
The report highlights Sanofi's financial and ESG performance for the fiscal year 2018, marking a return to growth with net sales of ’34.5 billion. The company advanced its strategic roadmap by building a leading rare blood disorder franchise and refocusing its R&D pipeline on specialty care. Sanofi strengthened its corporate social responsibility governance by integrating CSR into the Board's Appointments and Governance Committee and introducing a CSR performance criterion in the CEO's compensation. Key environmental achievements include a 9% reduction in CO2 emissions and a 14% reduction in water consumption since 2015, alongside joining the Science Based Targets initiative.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
2018
Fiscal Year
2018
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women in Management
Net Zero Target
Employees